Kookjeon Pharmaceutical Co., Ltd. (KOSDAQ:307750)

Kookjeon Pharmaceutical Revenue

Kookjeon Pharmaceutical had revenue of 34.67B KRW in the quarter ending March 31, 2026, a decrease of -9.44%. This brings the company's revenue in the last twelve months to 127.43B, down -5.92% year-over-year. In the year 2025, Kookjeon Pharmaceutical had annual revenue of 131.04B, down -3.98%.

• Revenue (ttm): 127.43B
• Revenue Growth: -5.92%
• P/S Ratio: 0.95
• Revenue / Employee: 715.88M
• Employees: 178
• Market Cap: 120.66B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	131.04B	-5.43B	-3.98%
Dec 31, 2024	136.47B	14.47B	11.86%
Dec 31, 2023	122.00B	18.29B	17.63%
Dec 31, 2022	103.71B	18.36B	21.51%
Dec 31, 2021	85.35B	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 28, 2026

Data Sources Report a data error